Another point, It will be interesting to see ho
Post# of 148163
(Total Views: 382)
Posted On: 03/29/2021 4:08:18 AM
Re: SizzlChest #84539
Another point,
It will be interesting to see how fast the FDA moves on RLFTF EUA if it is indeed submitted. I believe their trial was only 200 people, similar in size to ours. Let's see how they treat RLFTF. What words they use and what recommendations they make. They are a fellow small OTC biotech, maybe they help open the door for us??? Any positive news on small biotechs is good.
I am very curious to find out how the FDA responds to this particular company considering who is employed by it. Again, I have my thoughts but I will reserve judgement for now.
It will also be interesting to see how the share price responds and what happens to short interest in the stock. Also, if they do indeed get eua granted, how does the uplisting process playout? Do they reverse split? What requirements do they have to meet.
This can be a great learning experience and possibly give valuable insight into what we can expect.
It will be interesting to see how fast the FDA moves on RLFTF EUA if it is indeed submitted. I believe their trial was only 200 people, similar in size to ours. Let's see how they treat RLFTF. What words they use and what recommendations they make. They are a fellow small OTC biotech, maybe they help open the door for us??? Any positive news on small biotechs is good.
I am very curious to find out how the FDA responds to this particular company considering who is employed by it. Again, I have my thoughts but I will reserve judgement for now.
It will also be interesting to see how the share price responds and what happens to short interest in the stock. Also, if they do indeed get eua granted, how does the uplisting process playout? Do they reverse split? What requirements do they have to meet.
This can be a great learning experience and possibly give valuable insight into what we can expect.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼